Cargando…
Advantages and Limitations of Gene Therapy and Gene Editing for Friedreich’s Ataxia
Friedreich’s ataxia (FRDA) is an inherited, multisystemic disorder predominantly caused by GAA hyper expansion in intron 1 of frataxin (FXN) gene. This expansion mutation transcriptionally represses FXN, a mitochondrial protein that is required for iron metabolism and mitochondrial homeostasis, lead...
Autores principales: | Sivakumar, Anusha, Cherqui, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157421/ https://www.ncbi.nlm.nih.gov/pubmed/35663795 http://dx.doi.org/10.3389/fgeed.2022.903139 |
Ejemplares similares
-
CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
por: Rocca, Celine J., et al.
Publicado: (2020) -
Gene Edited T Cell Therapies for Inborn Errors of Immunity
por: Fox, T. A., et al.
Publicado: (2022) -
Base Editors for Citrus Gene Editing
por: Huang, Xiaoen, et al.
Publicado: (2022) -
Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia
por: Greene, Eriko, et al.
Publicado: (2007) -
Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2022)